ConductScience.org, home

Paper3085183

Uveal effusion in Hunter's syndrome. Evidence that abnormal sclera is responsible for the uveal effusion syndrome.

Vine AK. Retina, 1986. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. Uveal effusion in Hunter's syndrome. Evidence that abnormal sclera is responsible for the uveal effusion syndrome. Papers, record 3085183. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3085183

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Uveal effusion in Hunter's syndrome. Evidence that abnormal sclera is responsible for the uveal effusion syndrome.
PubMed
Journal
Retina
PubMed
Year
1986
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
1.23
iCite
Revised in PubMed
2006-12-15
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vine AKA K

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Exudates and TransudatesMajor topic
Mucopolysaccharidosis IIMajor topic
ScleraMajor topic
UveaMajor topic
Adult
Fundus Oculi
Humans
Male

Source PubMed

Download CSV of topics

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
35791104Mucopolysaccharidosis: A broad review.Indian J Ophthalmol2022https://conductscience.org/library/papers/35791104PubMed
35755052Uveal Effusion Syndrome: Clinical Characteristics, Outcome of Surgical Treatment, and Histopathological Examination of the Sclera.Front Med (Lausanne)2022https://conductscience.org/library/papers/35755052PubMed
35450194Clinical characteristics and surgical treatment of idiopathic uveal effusion syndrome.Int J Ophthalmol2022https://conductscience.org/library/papers/35450194PubMed
33993621Autophagy in the retinal pigment epithelium: a new vision and future challenges.FEBS J2022https://conductscience.org/library/papers/33993621PubMed
33653850Multimodal imaging to aid in diagnosis of uveal effusion syndrome type 3.BMJ Case Rep2021https://conductscience.org/library/papers/33653850PubMed
26376819Uveal effusion syndrome mimicking severe chronic posterior uveitis: a case series of seven eyes of four patients.Graefes Arch Clin Exp Ophthalmol2016https://conductscience.org/library/papers/26376819PubMed
25190538A case of Hunter syndrome with bilateral retinal detachment.Eye (Lond)2014https://conductscience.org/library/papers/25190538PubMed
18038146Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy.Eur J Pediatr2008https://conductscience.org/library/papers/18038146PubMed
1739704Exudative retinal detachment and posterior scleritis associated with massive scleral thickening and calcification treated by scleral decompression.Br J Ophthalmol1992https://conductscience.org/library/papers/1739704PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3085183

GET https://conductscience.org/api/papers/v1/3085183/authors